Search clinical trials for: MK0217, alendronate sodium / Duration of Treatment: 1 Month

Total 150 results

Merck Sharp & Dohme LLC

Completed

Upper GI Handling of Branded vs. Generic Alendronate

Osteoporosis
Organon and Co

Completed

A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)

Postmenopausal Osteoporosis
Organon and Co

Completed

FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

Osteoporosis, Postmenopausal
Organon and Co

Completed

A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)

Osteoporosis
Organon and Co

Completed

A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)

Osteoporosis, Postmenopausal
Merck Sharp & Dohme LLC

Completed

A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)

Vitamin D Deficiency | Osteoporosis
Organon and Co

Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)

Vitamin D Deficiency | Osteoporosis
Organon and Co

Completed

A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

Osteoporosis, Postmenopausal
Organon and Co

Completed

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

Osteoporosis, Postmenopausal
Shenzhen People's Hospital

Recruiting

Denosumab vs Alendronate After Vertebroplasty

Denosumab Allergy

China
Organon and Co

Completed

4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)

Osteoporosis
Merck Sharp & Dohme LLC

Completed

Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)

Urinary Tract Infections | Soft Tissue Infections | Bacterial Pneumonia
Centre Hospitalier Universitaire de Nīmes

Completed

Low Energy Shockwave Therapy for Improving Erectile Dysfunction (Shock-ED)

Erectile Dysfunction

France
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

Intra-abdominal Infection
University of Baghdad

Unknown

Efficacy of Antiresorptive and Bone Forming Material on Dental Implants

Partial Edentulism

Iraq
Organon and Co

Completed

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)

Migraine
Merck Sharp & Dohme LLC

Completed

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

Complicated Intra-Abdominal Infections
Sherief Abd-Elsalam

Recruiting

Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Beta Blocker Toxicity

Egypt
Sihuan Pharmaceutical Holdings Group Ltd.

Unknown

A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

Duodenal Ulcer，DU
Novartis

Terminated

Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH)

Hypertension

United States, Denmark, Finland, Norway, Sweden
Organon and Co

Completed

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)

Migraine
H. Lundbeck A/S

Completed

Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

Insomnia
Organon and Co

Completed

Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)

Migraine
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

Sepsis
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)

Pneumonia | Urinary Tract Infection | Infection
Organon and Co

Completed

MK0954A-264 Filter Study (0954A-264)(COMPLETED)

Mild to Severe Hypertension
Organon and Co

Completed

Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)

Migraine
Centre Francois Baclesse
University Hospital, Caen

Terminated

Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

France
Merck Sharp & Dohme LLC

Completed

A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)

Pneumonia | Infection
Ipsen

Terminated

Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment

Thyroid-Associated Ophthalmopathy

Spain
Organon and Co

Completed

TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

Hypercholesterolaemia | Hyperlipidaemia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers

Gastroesophageal Reflux

United States
Woman's Health University Hospital, Egypt

Completed

Clinical Guidance for Proper Treatment of Unexplained Resistant Hyperprolactinemia.

Health Education

Egypt
Organon and Co

Completed

A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)

Type 2 Diabetes | Nephropathy
Merck Sharp & Dohme LLC

Completed

Effect of MK0524A on Flushing Caused by Niacin (0524A-056)

Flushing
Sun Yat-sen University

Recruiting

Toripalimab With or Without Celecoxib as Neoadjuvant Therapy in Resectable dMMR/MSI-H Colorectal Cancer (PICC)

Colorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)

China
Merck Sharp & Dohme LLC

Completed

Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)

Arthritis, Rheumatoid
Merck Sharp & Dohme LLC

Completed

An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)

B-cell Lymphoma
Johnson & Johnson Consumer and Personal Products...

Completed

A Clinical Trial to Test the Effect of Marketed Mouth Rinses on Decreasing Plaque and Gum Inflammation

Gingivitis | Plaque

Canada
Merck Sharp & Dohme LLC

Completed

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

Foot Infections in Diabetic Patients
Merck Sharp & Dohme LLC

Completed

Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)

Mycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma
Organon and Co

Completed

A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

Asthma, Bronchial
Merck Sharp & Dohme LLC

Completed

Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED)

Pain, Postoperative Arthroscopy
AstraZeneca

Completed

Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants

Chronic Kidney Disease

United States
VA Office of Research and Development

Completed

Genetic Predictors of Lithium Response in Bipolar Disorder

Bipolar Disorder

United States
Organon and Co

Completed

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Hypertension | Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Terminated

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)

Multiple Myeloma
Organon and Co

Completed

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

Asthma
Organon and Co

Completed

MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)

Rhinitis Allergic
Organon and Co

Completed

Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)

Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)

3

Subscribe